Potential Role and Excretion Level of Urinary Transferrin, KIM-1, RBP, MCP-1 and NGAL Markers in Diabetic Nephropathy

References

• International Diabetes Federation. IDF diabetes atlas 8th Ed. International diabetes federation. 2017. Available from: http://www.diabetesatlas.org. Accessed October 9, 2018.
   Google Scholar
• Saudi Center for Organ Transplantation. Dialysis in the Kingdom of Saudi Arabia. SJKDT. 2017;28(4):949–957.
   Google Scholar
• International Society of Nephrology. Chapter 1: definition and classification of CKD. Kidney Int Suppl. 2013;3(1):19–62. doi:10.1038/kisup.2012.64
   Google Scholar
• Hashemipour S, Charkhchian M, Javadi A, et al. Urinary total protein as the predictor of albuminuria in diabetic patients. Int J Endocrinol Metab. 2012;10(3):523–526. doi:10.5812/ijem.4236
   PubMedGoogle Scholar
• Yamamoto K, Yamamoto H, Yoshida K, et al. The total urine protein-to-creatinine ratio can predict the presence of microalbuminuria. PLoS One. 2014;9(3):e91067. doi:10.1371/journal.pone.0091067
   PubMedGoogle Scholar
• Atkins RC, Briganti EM, Zimmet PZ, Chadban SJ. Association between albuminuria and proteinuria in the general population: the AusDiab Study. Nephrol Dial Transplant. 2003;18(10):2170–2174. doi:10.1093/ndt/gfg314
   PubMed Web of Science ®Google Scholar
• Cohen-Bucay A, Viswanathan G. Urinary markers of glomerular injury in diabetic nephropathy. Int J Nephrol. 2012;2012:146987. doi:10.1155/2012/146987
   PubMedGoogle Scholar
• Kanauchi M, Nishioka H, Hashimoto T, Dohi K. Diagnostic significance of urinary transferrin in diabetic nephropathy. Nihon Jinzo Gakkai Shi. 1995;37(11):649–654.
   PubMedGoogle Scholar
• Titan SM, Vieira JM, Dominguez WV, et al. Urinary MCP-1 and RBP: independent predictors of renal outcome in macroalbuminuric diabetic nephropathy. J Diabetes Complicat. 2012;26(6):546–553. doi:10.1016/j.jdiacomp.2012.06.006
   PubMed Web of Science ®Google Scholar
• Al-Refai AA, Tayel SI, Ragheb A, Dala AG, Zahran A. Urinary neutrophil gelatinase associated lipocalin as a marker of tubular damage in type 2 diabetic patients with and without albuminuria. Open J Nephrol. 2014;2014.
   Google Scholar
• Kin Tekce B, Tekce H, Aktas G, Sit M. Evaluation of the urinary kidney injury molecule-1 levels in patients with diabetic nephropathy. Clin Invest Med. 2014;37(6):E377–E383. doi:10.25011/cim.v37i6.22242
   PubMed Web of Science ®Google Scholar
• Shoukry A, Bdeer SE-A, El-Sokkary RH. Urinary monocyte chemoattractant protein-1 and vitamin D-binding protein as biomarkers for early detection of diabetic nephropathy in type 2 diabetes mellitus. Mol Cell Biochem. 2015;408(1–2):25–35. doi:10.1007/s11010-015-2479-y
   PubMed Web of Science ®Google Scholar
• Al-Rubeaan K, Siddiqui K, Alghonaim M, Youssef AM, AlNaqeb D. The Saudi Diabetic Kidney Disease study (Saudi-DKD): clinical characteristics and biochemical parameters. Ann Saudi Med. 2018;38(1):46–56. doi:10.5144/0256-4947.2018.03.01.1010
   PubMed Web of Science ®Google Scholar
• World Medical Association. World Medical Association Declaration of Helsinki: ethical principles for medical research involving human subjects. JAMA. 2013;310(20):2191–2194. doi:10.1001/jama.2013.281053
   PubMed Web of Science ®Google Scholar
• Ketteler M, Block GA, Evenepoel P, et al. Diagnosis, evaluation, prevention, and treatment of chronic kidney disease-mineral and bone disorder: synopsis of the kidney disease: improving global outcomes 2017 clinical practice guideline update. Ann Intern Med. 2018;168(6):422–430. doi:10.7326/M17-2640
   PubMed Web of Science ®Google Scholar
• American Diabetes Association. Nephropathy in diabetes. Diabetes Care. 2004;27(suppl 1):s79–s83. doi:10.2337/diacare.27.2007.S79
   PubMedGoogle Scholar
• National Institute of Diabetes and Digestive and Kidney Diseases. Quick reference on UACR & GFR | NIDDK. National Institute of Diabetes and Digestive And Kidney Diseases. Available from: https://www.niddk.nih.gov/health-information/professionals/clinical-tools-patient-education-outreach/quick-reference-uacr-gfr. Accessed October 2, 2019.
   Google Scholar
• Levey AS, Stevens LA, Schmid CH, et al. A new equation to estimate glomerular filtration rate. Ann Intern Med. 2009;150(9):604–612. doi:10.7326/0003-4819-150-9-200905050-00006
   PubMed Web of Science ®Google Scholar
• Williams ME. Diabetic nephropathy: the proteinuria hypothesis. Am J Nephrol. 2005;25(2):77–94. doi:10.1159/000084286
   PubMedGoogle Scholar
• Fatrinawati W, Sianipar O. Sensitivity of total protein creatinine ratio in urine for diagnosis diabetic nephropathy. J Med Sci. 2017;49(2):64–71. doi:10.19106/JMedSci004902201703
   Google Scholar
• Kulasooriya PN, Bandara SN, Priyadarshani C, et al. Prediction of microalbuminuria by analysing total urine protein-to-creatinine ratio in diabetic nephropathy patients in rural Sri Lanka. Ceylon Med J. 2018;63(2):72–77. doi:10.4038/cmj.v63i2.8687
   PubMedGoogle Scholar
• Fiseha T, Tamir Z. Urinary markers of tubular injury in early diabetic nephropathy. Int J Nephrol. 2016;2016:4647685. doi:10.1155/2016/4647685
   PubMedGoogle Scholar
• Hong CY, Chia KS, Ling SL. Urinary protein excretion in type 2 diabetes with complications. J Diabetes Complicat. 2000;14(5):259–265. doi:10.1016/S1056-8727(00)00119-7
   PubMedGoogle Scholar
• Mori K, Nakao K. Neutrophil gelatinase-associated lipocalin as the real-time indicator of active kidney damage. Kidney Int. 2007;71(10):967–970. doi:10.1038/sj.ki.5002165
   PubMed Web of Science ®Google Scholar
• Assal HS, Tawfeek S, Rasheed EA, El-Lebedy D, Thabet EH. Serum cystatin C and tubular urinary enzymes as biomarkers of renal dysfunction in type 2 diabetes mellitus. Clin Med Insights Endocrinol Diabetes. 2013;6:7–13. doi:10.4137/CMED.S12633
   PubMedGoogle Scholar
• Segerer S, Nelson PJ, Schlöndorff D. Chemokines, chemokine receptors, and renal disease: from basic science to pathophysiologic and therapeutic studies. J Am Soc Nephrol. 2000;11(1):152–176.
   PubMed Web of Science ®Google Scholar
• Wada T, Furuichi K, Sakai N, et al. Up-regulation of monocyte chemoattractant protein-1 in tubulointerstitial lesions of human diabetic nephropathy. Kidney Int. 2000;58(4):1492–1499. doi:10.1046/j.1523-1755.2000.00311.x
   PubMed Web of Science ®Google Scholar
• Mahfouz MH, Ellakwa DE, Bassyoni AA. Assessment of monocyte chemoattractant protein-1 (MCP-1) in type 2 diabetic patients with nephropathy. Int J Adv Health Sci. 2015;2(5):606–623.
   Google Scholar
• Ibrahim S, Rashed L. Correlation of urinary monocyte chemo-attractant protein-1 with other parameters of renal injury in type-II diabetes mellitus. Saudi J Kidney Dis Transpl. 2008;19(6):911–917.
   PubMedGoogle Scholar
• Han WK, Bailly V, Abichandani R, Thadhani R, Bonventre JV. Kidney Injury Molecule-1 (KIM-1): a novel biomarker for human renal proximal tubule injury. Kidney Int. 2002;62(1):237–244. doi:10.1046/j.1523-1755.2002.00433.x
   PubMed Web of Science ®Google Scholar
• van Timmeren MM, van den Heuvel MC, Bailly V, Bakker SJL, van Goor H, Stegeman CA. Tubular kidney injury molecule-1 (KIM-1) in human renal disease. J Pathol. 2007;212(2):209–217. doi:10.1002/path.2175
   PubMed Web of Science ®Google Scholar